> top > projects > Inflammaging > docs > PubMed:32246317 > annotations
Inflammaging  

PubMed:32246317 JSONTXT 15 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 0-99 Sentence denotes Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.
T1 0-99 Sentence denotes Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.
T2 100-311 Sentence denotes Severe coronavirus disease 2019 (COVID-19) is commonly complicated with coagulopathy, the difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 has not been analyzed.
T2 100-311 Sentence denotes Severe coronavirus disease 2019 (COVID-19) is commonly complicated with coagulopathy, the difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 has not been analyzed.
T3 312-533 Sentence denotes Coagulation results and clinical features of consecutive patients with severe pneumonia induced by SARS-CoV2 (COVID group) and non-SARS-CoV2 (non-COVID group) in Tongji hospital were retrospectively analyzed and compared.
T3 312-533 Sentence denotes Coagulation results and clinical features of consecutive patients with severe pneumonia induced by SARS-CoV2 (COVID group) and non-SARS-CoV2 (non-COVID group) in Tongji hospital were retrospectively analyzed and compared.
T4 534-630 Sentence denotes Whether patients with elevated D-dimer could benefit from anticoagulant treatment was evaluated.
T4 534-630 Sentence denotes Whether patients with elevated D-dimer could benefit from anticoagulant treatment was evaluated.
T5 631-712 Sentence denotes There were 449 COVID patients and 104 non-COVID patients enrolled into the study.
T5 631-712 Sentence denotes There were 449 COVID patients and 104 non-COVID patients enrolled into the study.
T6 713-1013 Sentence denotes The 28-day mortality in COVID group was approximately twofold of mortality in non-COVID group (29.8% vs. 15.4%, P = 0.003), COVID group were older (65.1 ± 12.0 vs. 58.4 ± 18.0, years, P < 0.001) and with higher platelet count (215 ± 100 vs. 188 ± 98, ×109/L, P = 0.015), comparing to non-COVID group.
T6 713-1013 Sentence denotes The 28-day mortality in COVID group was approximately twofold of mortality in non-COVID group (29.8% vs. 15.4%, P = 0.003), COVID group were older (65.1 ± 12.0 vs. 58.4 ± 18.0, years, P < 0.001) and with higher platelet count (215 ± 100 vs. 188 ± 98, ×109/L, P = 0.015), comparing to non-COVID group.
T7 1014-1146 Sentence denotes The 28-day mortality of heparin users were lower than nonusers In COVID group with D-dimer > 3.0 μg/mL (32.8% vs. 52.4%, P = 0.017).
T7 1014-1146 Sentence denotes The 28-day mortality of heparin users were lower than nonusers In COVID group with D-dimer > 3.0 μg/mL (32.8% vs. 52.4%, P = 0.017).
T8 1147-1354 Sentence denotes Patients with severe pneumonia induced by SARS-CoV2 had higher platelet count than those induced by non-SARS-CoV2, and only the former with markedly elevated D-dimer may benefit from anticoagulant treatment.
T8 1147-1354 Sentence denotes Patients with severe pneumonia induced by SARS-CoV2 had higher platelet count than those induced by non-SARS-CoV2, and only the former with markedly elevated D-dimer may benefit from anticoagulant treatment.